Eikon Therapeutics

cash money
Biotech

Biotech's top money raisers: 2025

While 2024 marked the return of the biotech megaround, 2025 proved that it wasn’t just a one-year anomaly.
Gabrielle Masson Mar 2, 2026 6:30am
IPO initial public offering Wall Street

Eikon upsized $381M listing marks largest biotech IPO since 2024

Feb 5, 2026 4:23am
money funding financing bank

Eikon sets $274M goal for upcoming stock market debut

Jan 28, 2026 2:00pm
IPO initial public offering

Eikon plans IPO to bankroll clutch of clinical cancer drugs

Jan 12, 2026 4:40am
Conceptual illustration of layoffs featuring rows of translucent human figures overlaid with large blue scissors symbolizing

Biopharma layoffs hit 4-year monthly high in May

Jul 8, 2025 2:26pm
A series of dice with a bag on them illustrating cost cuts

Eikon blames US cuts for 15% staff reduction

May 22, 2025 7:55am